The present invention provides a compound represented by the following general formula (I):
or a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing such a compound, and the like. The compound or a pharmaceutically acceptable salt thereof, the pharmaceutical composition containing such a compound, or the like is useful as a medicine or the like for therapy of benign prostatic hyperplasia, cancer, osteoporosis, psoriasis, secondary hyperparathyroidism, chronic glomerulonephritis, lupus nephritis and/or diabetic nephropathy and the like.
Pyrrolo[3,2,1-ij]quinoline-4-one derivatives for treating tuberculosis
申请人:GLAXO GROUP LIMITED
公开号:EP1980251A1
公开(公告)日:2008-10-15
Tricyclic nitrogen-containing compounds of Formula (I) and pharmaceutically acceptable derivatives thereof:
compositions containing them, their use in the treatment of tuberculosis, and methods for the preparation of such compounds.
Described herein are novel divalent nucleobases that each bind two nucleic acid strands, matched or mismatched when incorporated into a nucleic acid or nucleic acid analog backbone (a genetic recognition reagent, or genetic recognition reagent). In one embodiment, the genetic recognition reagent is a peptide nucleic acid (PNA) or gamma PNA (?PNA) oligomer. Uses of the divalent nucleobases and monomers and genetic recognition reagents containing the divalent nucleobases also are provided.
Process for preparing hyperpolarized substrates and method for MRI
申请人:Aime Silvio
公开号:US09694090B2
公开(公告)日:2017-07-04
The present invention generally relates to a process for the preparation of aqueous solutions of hyperpolarized molecules ready for use in in-vivo MR diagnostic imaging, the use thereof as MRI contrast agent in investigation methods for producing diagnostic MR images of a human or non-human animal body organ, region or tissue.